Companies in #mRNA Therapeutics
Found 3 companies operating in this sector.
Abogen Biosciences
PrivateClinical-stage RNA therapeutics company developing mRNA medicines — prophylactic vaccines and cancer and autoimmune disease therapies — on its proprietary lipid-nanoparticle delivery platform.
Arcturus Therapeutics is a messenger RNA medicines company focused on liver and respiratory rare diseases, built on the STARR self-amplifying mRNA platform and the LUNAR lipid-mediated delivery system. Its pipeline includes ARCT-032 (LUNAR-CF, an mRNA therapeutic candidate for cystic fibrosis in Phase 2), ARCT-810 (LUNAR-OTC for ornithine transcarbamylase deficiency, Phase 2), KOSTAIVE (a self-amplifying COVID-19 vaccine approved in Japan), and Phase 1 influenza (ARCT-2138) and pandemic-influenza (ARCT-2304) programs. Headquartered in San Diego, the company beat Q2 2026 earnings estimates by $0.16 per share and traded up 21.9% on August 7, 2026 on above-average volume.
BioNTech is a public biotechnology company developing mRNA-based medicines, cancer immunotherapies, infectious-disease vaccines, and antibody-based oncology programs.